Specialty

Ziconotide: informing intrathecal risk assessment

16 May 2025Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Clonidine: informing intrathecal risk assessment

16 May 2025Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Baclofen: informing intrathecal risk assessment

7 May 2025Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Choosing an antidepressant for people with coronary heart disease

29 April 2025Sertraline is the first-line option in people with coronary heart disease. Alternatives include fluoxetine, paroxetine and mirtazapine.

Intravenous hyoscine butylbromide

24 April 2025SPS PGD template for administering intravenous hyoscine butylbromide for imaging investigations by registered Radiographers.

Using potassium permanganate for skin conditions or wound care

4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.

Pain: treatment during pregnancy

3 April 2025A summary of pharmacological options commonly used to treat pain in primary care.

Estimating dose equivalence from oral morphine to other opioids

1 April 2025Use our tool to obtain approximate dose equivalences of oral morphine to other oral opioids and help you calculate an estimated equivalent daily dose.

Switching between morphine and other opioids in palliative care

1 April 2025Switching between oral morphine and other oral opioids requires care and thoughtful application of a stepped process.

Supporting people with sight loss in managing their medicines

20 March 2025Guidance for pharmacy staff about how to support people with sight loss in using their medicines and accessing pharmacy services.

SPS - Specialist Pharmacy Service

NHS